TJX Companies Operating Cash Flow increased by 184.0% to $1.12B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 184.0%, from $394.00M to $1.12B. Over 3 years (FY 2022 to FY 2025), Operating Cash Flow shows an upward trend with a 26.0% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q1 '27 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$432.73M | $438.73M | $1.05B | $2.00B | -$634.00M | $2.72B | $1.17B | $827.00M | $745.00M | $1.62B | $1.05B | $2.65B | $737.00M | $1.45B | $1.53B | $2.40B | $394.00M | $1.12B |
| QoQ Change | — | +201.4% | +140.0% | +89.7% | -131.7% | +529.0% | -56.9% | -29.4% | -9.9% | +117.6% | -35.5% | +152.9% | -72.1% | +96.5% | +5.8% | +56.6% | -83.6% | +184.0% |
| YoY Change | — | — | — | — | -46.5% | +520.0% | +11.2% | -58.6% | +217.5% | -40.4% | -10.7% | +219.8% | -1.1% | -10.7% | +46.5% | -9.3% | -46.5% | +184.0% |